Advancing Addiction Science to Address the Opioid Crisis
|
|
- Diane Beasley
- 5 years ago
- Views:
Transcription
1 Advancing Addiction Science to Address the Opioid Crisis National Institute on Drug Abuse Bringing the full power of science to bear on drug abuse and addiction Nora D. Volkow, M.D. Director National Institute on Drug Abuse Science = Solutions Advancing Addiction Science Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
2 Overdose Deaths Increased Markedly in ,000 60,000 63,632 50,000 40,000 47,055 52,404 30,000 20,000 10, ,
3 Virtually All of the U.S. Have Increased Drug Overdoses: Estimated Age-adjusted Death Rates for Drug Poisoning by County
4 Overdose Deaths Primarily from Opioids: Prescription Drugs, Heroin and Synthetics (i.e. Fentanyl and similar) Other Synthetic Opioids (e.g. fentanyl) Commonly Prescribed Opioids (natural and semi-synthetic opioids and methadone) Heroin Methadone
5 ENVIRONMENTAL AVAILABILITY: Current Opioid Crisis Originated with Prescribing Increases 250 Opioid prescriptions Tripled to MORE THAN 200 MILLION prescriptions in recent years Opioid Prescriptions in MILLIONS
6 People Misusing Analgesics Obtain them Directly & Indirectly by Prescription Source where pain relievers obtained for most recent misuse Prescription 36% Friend/ Relative 87% Their Prescription 10% Other 54% Other 3% 10% Their Friend/Relative Source: Han, Compton, et al. Annals of Internal Medicine 2017;167(5):
7 Women suffer more pain in many categories and are prescribed more opioids Rates of U.S. Adults > 18 and Older Reporting Pain, Severe headache or migraine Number of `Prescription Low back pain Males Females Men Neck pain Women CDC and NCHS, 2015 Opioid Prescriptions U.S. Retail Pharmacies, Source: IMS Health, National Prescription Audit
8 Analgesic Mechanisms of Mu Opiate Drugs (Heroin, Vicodin, Morphine) ACC (pain) Accumbens (reward) PAG (pain) Thalamus (pain)
9 Rx Opioid Misuse has been a Risk Factor for Heroin Use % Heroin Treatment Admissions that Used Heroin or Rx Opioid First Most current heroin users started opioid use with prescription opioids. Decade of First Opioid Use (No. of Abusers) Source: Cicero et al. JAMA Psychiatry. 2014;71(7):
10 Most Heroin Users Report Previous Non-Medical Use of Prescription Opioids, BUT Only a Small Proportion of Non-Medical Users Progress to Heroin National General Population: Within 5 years, 3.6% of non-medical users of opioids progressed to heroin within 5 years (i.e. less than 1% per year) (Muhuri, Gfroerer, Davies. 2013) Local Longitudinal Study of Non-medical users: Within 3 years, 7.5% progressed to heroin (i.e. 2.8% per year) (Carlson, Nahhas, martins, Daniulaityte. 2015)
11 Heroin Users: First Opioid Now Likely to be Heroin Source: Cicero T et al. Addictive Behaviors 2017;74:63-66
12 ECONOMICS: Heroin Increases Due to Lower Price and Greater Availability $3,500 "Retail" Price Per Pure Gram $3,000 $2,500 $2,000 $1,500 $1,000 $500 $ National Drug Control Strategy--Data Supplement
13 Fentanyl and Counterfeit Products Broaden Risk Population Source: Jones CM, et al. AJPH 2017, Mar;107(3):
14 2016 Fentanyl-Related Deaths Surpassed Heroin or Rx Graphs from NY Times Article based on CDC MMWR Report 2017
15 ECONOMICS: CHEAP Fentanyl Precursor Chemicals
16 Increasing Prenatal Exposure Admissions for Newborn Withdrawal Syndromes (Number per 1000 Admissions) Source: Tolia VN, Patrick SW, et al. NEJM 2015;372: Science = Solutions
17 Rising rates of HCV Counties Deemed Highly Vulnerable to Rapid Dissemination of HCV or HIV Suryaprasad et al. Clin Infect Dis HIV (and Hepatitis C) Outbreak Linked to Oxymorphone Injection Use in Indiana, 2015 Peters et al. The New England Journal of Medicine 2016;375: Source: Van Handel et al, JAIDS 2016
18 Science = Solutions: Using Research to Improve HIV and Hepatitis C in Rural Areas NIH is partnering with the CDC, SAMHSA and the Appalachian Regional Commission (ARC) to conduct research to address increased opioid injection drug use and resulting overdose, HIV and Hepatitis C infection. Improve understanding problem s scope; contributing health trends Identify resources, obstacles Develop intervention approaches to address these health threats
19 Overlap of Benzodiazepines and Opioids Opioid Analgesic ED Visits and OD Deaths Involving Benzodiazepines & Benzodiazepine ED Visits and OD Deaths Involving Opioids AAPC = 1.5% (95% CI 0.8%-2.2%) Percent AAPC = 8.4% (95% CI 7.1%-9.7%) 0 Opioid Analgesic Deaths Involving Benzodiazepines Opioid Analgesics Benzodiazepine Deaths Involving Opioid Analgesics Benzodiazepines Source: CM Jones, JK McAninch. American Journal of Preventive Medicine 2015;49: Science = Solutions
20 U.S. Department of Health and Human Services OPIOID STRATEGY Targeting availability and distribution of overdosereversing drugs Advancing the practice of pain management Comprehensive Evidence-based Targets drivers of epidemic Flexible to emerging threats Improving access to prevention, treatment, and recovery services Supporting cutting-edge research Strengthening timely public health data and reporting
21 Inadequate Pain Treatment as a Driver? 91.8 million adults used prescription opioids (37.8% of the U.S. adult population) million adults misused prescription opioids (4.7% of the U.S. adult population) 1.9 million adults had prescription opioid use disorders (0.8% of the U.S. adult population) relieve physical pain 4.6 relax or relieve tension experiment get high or feel good help with sleep help with emotions or feelings increase/decrease effects of other drugs hooked or have to misuse other reason 8.9 Source: Han, Compton, et al. Annals of Internal Medicine 2017 (epub Aug 1, 2017)
22 Limited Medical Education on Pain (and Addiction) Pain Education in USA: 9 Mean Hours (range 1-31) Number of med schools teaching 0 to 5 hours, 5 to 10 hours, etc.. U.S. medical schools dark gray bars, Canadian schools light gray. Mezei L, et al. Pain education in North American medical schools J Pain. 2011
23 Doctors Continue to Prescribe Opioids for Ninety-one Percent of Overdose Patients In a 2-year follow-up of 2848 commercially insured patients who had a nonfatal opioid overdose during long-term opioid therapy : 14% 13% 63% of highdose opioid pts still on high dose days after OD 17% of high- dose patients overdosed again within two years high dose moderate dose low dose none Ø33-39% of those with active opioid prescriptions during follow-up also were prescribed benzodiazepines. Source: Larochelle et al. Ann Intern Med. 2016;164(1):1-9.
24 Ø Recent Landscape for Guidelines: Small Number Outdated Not Conflict Free ØSolution. Opioid Prescribing Guidelines Ø Intended for primary care providers Ø Applies to patients >18 years old in chronic pain outside of end-of-life care Ø Builds on joint CDC, NIDA, ONC, SAMHSA summary on Common Elements in Guidelines for Prescribing Opioids for Chronic Pain and the NIH Pathways to Prevention for Opioids in Treating Chronic Pain Ø PUBLISHED MARCH 15, 2016
25 Opioid Education Resources for Medical Students, Resident Physicians & Faculty Medical schools have developed innovative curriculum resources about how to identify and treat patients with substance use disorders Web training on pain assessment and treatment Archived NIDA CME Courses: Safe Prescribing for Pain Managing Pain Patients Who Abuse Rx Drugs Bringing NIDA research to clinical practice Upcoming NIDA CME Course: Adolescent Substance Use (Prescription Opioid Module)
26 Recent Declines in Opioid Prescriptions 70 Opioid MME in BILLIONS Opioid Morphine Milligram Equivalents Prescribed Declined 23.1% from 3 rd quarter 2010 to 2 nd quarter Q2010 2Q2010 3Q2010 4Q2010 1Q2011 2Q2011 3Q2011 4Q2011 1Q2012 2Q2012 3Q2012 4Q2012 1Q2013 2Q2013 3Q2013 4Q2013 1Q2014 2Q2014 3Q2014 4Q2014 1Q2015 2Q2015 3Q2015 4Q2015 1Q2016 2Q2016
27 RESEARCH TARGET: Safe, Effective Strategies for Pain Management
28 A Promising New Generation Of Pain Therapeutics Biased Mu-Opioid Receptor Ligands Soergel DG, et al., Pain Manglik A, et al., Nature DeWire SM, et al., JPET Bohn LM, et al., Science 1999 Science = Solutions
29 Research on the Neurobiology of Pain Gender Differences in Kappa Opioid Receptor Availability Males Female s Males had higher K opioid receptor availability than females presumably from increased dynorphin. Could this help explain gender differences in pain catastrophizing?? Vijay et al., Am J Nucl Med Mol Imaging (4):
30 Direct Overdose Intervention Naloxone Distribution for opioid overdose victims. The potential for direct intervention to save lives. Ø Evzio naloxone auto-injector APPROVED BY FDA, April 3, 2014 Ø Narcan Nasal Spray naloxone APPROVED BY FDA, November 18, 2015 Science = Solutions
31 NALOXONE REQUIRES FAST AND EFFICIENT DELIVERY as achieved with iv injection but few know how to inject Receptor occupancy by INTRANASAL equivalent to INTRAVENOUS Naloxone Baseline Intranasal Intravenous Positive pharmacology of nasal naloxone: Rapid onset and high peak blood level 1 0 N alo x o n e P lasm a C o n cen tratio n (n g /m L ) Blood Concentration Intranasal Narcan Injectable 2 x 4 0 m g /m L IN 2 x 2 0 m g /m L IN 1 x 4 0 m g /m L IN 1 x 2 0 m g /m L IN 0.4 m g IM Phillip et al. J Pharmacol ExpTher H o u rs P o s td o s e
32 Retail Pharmacy Prescriptions for Naloxone Increase Markedly Retail prescriptions show an increase of 9520% from the 4 th quarter of 2013 to 2 nd quarter Outpatient prescribing of naloxone may complement community-based distribution and first responder access Q2010 3Q2010 1Q2011 3Q2011 1Q2012 3Q2012 1Q2013 3Q Q2014 3Q2014 Sources: Jones CM, Lurie PG, Compton WM. Am J Public Health. 2016;106(4): ; IMS Health, published Q Q2015 1Q2016 Science = Solutions
33 Medications are Effective for Opioid Use Disorder Medication Assisted Treatment (MAT) can DECREASE: Opioid use Opioid-related overdose deaths Criminal activity Infectious disease transmission And INCREASE Social functioning Retention in treatment Kakko J et al., The Lancet 2003.
34 Effective Medications for Opioid Addiction Full Agonist: Methadone (daily dosing) Partial Agonist: Buprenorphine (3-4X week, or implant) Antagonists: Naltrexone (monthly extended release) agonist antagonist no effect effect Binds to receptor but has no effect. Binds to the receptor and Prevents heroin from activates it; binding. Full agonists have maximal effect. Partial agonist have intermediate effect. Prevent Heroin from binding. Opioid Effect Full Agonist (Methadone) Partial Agonist (Buprenorphine Antagonist (Naltrexone) Log Dose Science = Solutions
35 Medications are Underused In 48 states and D.C., Opioid Abuse and Dependence Rates Exceed Buprenorphine Treatment Capacity In 2014, only 25% of opioid admissions had treatment plans that included receiving medications. 75% 25% Jones C et al., Am J Public Health MAT No MAT Treatment Episode Data Set (TEDS):
36 Science Driven Solutions: Improving Addiction Treatment Probuphine: buprenorphine implant; releases sustained dose for up to 6 months (FDA Approval May 26, 2016) Initiating buprenorphine treatment in the emergency department improves treatment engagement and reduces illicit opioid use Extended release naltrexone initiated in criminal justice settings lowers relapse rates and overdoses Abstinence from opioids over 12 Weeks with interim buprenorphine Abstinence with Interim Buprenorphine Lee JD, et al., Addiction 2015;100: and New EngJ Med 2016;374: Sigmon SC et al. N Engl J Med 2016.
37 Antibodies and Vaccines to Treat OUD and Prevent Overdose Heroin vaccine validated in primate model in 2017 First vaccine for fentanyl and fentanyl analogs reported in a mouse model in 2016 Reduces drug reaching the brain Protect high-risk individuals against overdose Bremer et al, 2017; Bremer et al, 2016; Janda and Treweek, 2012.
38 Non-Pharmacological Treatments for Addiction Transcranial Magnetic Stimulation (TMS) Transcranial Direct Current Simulation (tdcs) Deep Brain Stimulation (DBS) Implanted electrodes emit electrical stimulation to targeted brain region Salling and Martinez, 2016.
39 NIH Opioid Research Initiative Using Research to End the Opioid Crisis PAIN MANAGEMENT Safe, effective, non-addictive strategies OPIOID ADDICTION TREATMENT New, innovative medications and technologies Nonpharmacological Treatments (e.g. TMS) Opioid Vaccines Biomarkers For Pain Non-Opioid Analgesics Respiratory Stimulation Devices OVERDOSE REVERSAL Interventions to reduce mortality and link to treatment
40 Summary: Complex biological, developmental and social aspects of substance use and addiction suggest multipronged responses. The severity of the opioid crisis demands urgent action. Science = Solutions Advancing Addiction Science
Advancing Addiction Science to Address the Opioid Crisis
Advancing Addiction Science to Address the Opioid Crisis National Institute on Drug Abuse Bringing the full power of science to bear on drug abuse and addiction Nora D. Volkow, M.D. Director National Institute
More informationThe opioid crisis: A view from NIDA
The opioid crisis: A view from NIDA National Institute on Drug Abuse Bringing the full power of of science to bear to bear on drug on drug abuse abuse and addiction and addiction Nora D. Volkow, M.D. Director
More informationNIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:
More informationThe Opioid Epidemic: HHS Response
The Opioid Epidemic: HHS Response Christopher M. Jones, PharmD, MPH Acting Associate Deputy Assistant Secretary (Science and Data Policy) Office of the Assistant Secretary for Planning and Evaluation U.S.
More informationPolicy Implications of the Neurobiology of Addiction
Policy Implications of the Neurobiology of Addiction Facilitator: Jay Butler, MD, President of ASTHO, Chief Medical Officer Alaska Department of Health and Social Services Director, Alaska Division of
More informationChronic Pain in Women and its Relationship to Opioid Addiction
Chronic Pain in Women and its Relationship to Opioid Addiction Advancing Addiction Science Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse OPIOIDS are Powerful Analgesics
More informationInnovative Research and the Opioid Epidemic: Are We Closer to Finding Solutions? October 13, :00 3:00 p.m. ET Webinar
Innovative Research and the Opioid Epidemic: Are We Closer to Finding Solutions? October 13, 2017 2:00 3:00 p.m. ET Webinar The Role of Research in Finding Solutions to the Opioid Epidemic Nora D. Volkow,
More informationNational Academies of Sciences, Engineering, and Medicine Forum on Neuroscience and Nervous System Disorders
National Academies of Sciences, Engineering, and Medicine Forum on Neuroscience and Nervous System Disorders Workshop: Advancing Therapeutic Development for Pain and Opioid Use Disorders through Public-Private
More informationResponding to the Opioid Morbidity and Mortality Crisis
Session ID: 17 16 Disclosures of Interests: Wilson M. Compton, MD, MPE Long-Term Stock Equity (unrelated to the presentation): 3M Company (under $1,) General Electric Corporation (under $1,) Pfizer, Inc.
More informationHHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder
HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationChanging Federal Health Care Policies
Changing Federal Health Care Policies A view from NIDA Carlos Blanco, M.D., Ph.D. Director Division of Epidemiology, Services and Prevention National Institute on Drug Abuse Advancing Addiction Science
More informationStrategies to Manage The Opioid Crisis
Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor
More informationScience = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse
Advancing Addiction Science Science = Solutions Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse John Smith James Smith Ann
More informationSC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC
SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a
More informationOpioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationMedication Assisted Treatment for Opioid Use Disorders and Veteran Populations
Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationPrescription Opioids
What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationPrescription Opioids and Heroin
National Institute on Drug Abuse (NIDA) Prescription Opioids and Heroin Last Updated January 2018 https://www.drugabuse.gov 1 Table of Contents Prescription Opioids and Heroin Introduction Prescription
More information2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
More informationOpioid Harm Reduction
Opioid Harm Reduction Lucas G. Hill, PharmD Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Clinical Pharmacist, CommUnityCare FQHCs Director, Operation Naloxone Mark
More informationNational Academy of Medicine Action Collaborative: Countering the US Opioid Epidemic
National Academy of Medicine Action Collaborative: Countering the US Opioid Epidemic Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioids and Mental Health Policy @HHS_ASH
More informationMedication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford
Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand
More information2/20/2019. Source: Source:
The misuse of and addiction to opioids including prescription pain relievers, heroin, and synthetic opioids such as fentanyl is a serious national crisis that affects public health as well as social and
More informationOpioid Overdose in Oregon Report to the Legislature
SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing
More informationOpioid Treatment in North Carolina SEPTEMBER 13, 2016
Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained
More informationPolicy and Political Dynamics of the Opioid Addiction Crisis in the United States
Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas
More informationOPIOIDS IN AMERICA. A complex crisis. A comprehensive response.
OPIOIDS IN AMERICA A complex crisis. A comprehensive response. Prescription opioids play a critical role in helping millions of people effectively manage chronic pain. But for some, opioid use has become
More informationOpioid Overview Admiral Brett P. Giroir, M.D.
A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE
More informationAddressing Alaska s Opioid Epidemic From Understanding to Action
Addressing Alaska s Opioid Epidemic From Understanding to Action The opioid epidemic is devastating American families and communities. To curb these trends and save lives, we must help prevent addiction
More informationNaloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties
Naloxone Statewide Standing Order Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Objectives Review the US & NC trends on opioid overdose Understand key
More informationHeroin. What is heroin?
What is heroin? Heroin Heroin is an opioid drug made from morphine, a natural substance taken from the seed pod of the Asian opium poppy plant. Heroin can be a white or brown powder, or a black sticky
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationCDC s Efforts to End the Opioid Epidemic
Amy Insert Peeples, CIO Name MPA Here Deputy Director, National Center for Injury Prevention and Control NCSL Opioid Policy Fellows Kick Off CDC s Efforts to End the Opioid Epidemic The Epidemic in America
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationOpioid Use Disorders &Medication Treatment
Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationPresentation at National Academies of Sciences Engineering Medicine
FOCUSED ON ADDICTION Presentation at National Academies of Sciences Engineering Medicine 11 th October 2017 COI statement Full time employee of Opiant Pharmaceuticals Inc. Shareholder of Opiant Pharmaceuticals
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationOpioid Task Force Kick-Off Meeting. February 29, 2016
Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationMedications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationOPIOID TRENDS IN PIERCE COUNTY. February 2017
OPIOID TRENDS IN PIERCE COUNTY February 2017 Prepared by the Alcohol and Drug Abuse Institute, University of Washington Report written under contract with Tacoma Pierce County Health Department by Caleb
More informationEpidemiologic Data on Opioid Use: Changing Problems
Epidemiologic Data on Opioid Use: Changing Problems 1 Goals 1 To bridge the pain world and addiction world 1. Pain and pain treatment a. Chronic pain affects an estimated 100 million Americans (1/3 of
More informationThe Challenge of Treating Pain
FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationAGENDA U.S. SURGEON GENERAL, VIVEK MURTHY MD 2/5/2019
FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5
More informationU.S. SURGEON GENERAL, VIVEK MURTHY MD
FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5
More informationNARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE
NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE Stephanie Nichols, PharmD, BCPS, BCPP Associate Professor, Husson University Nicholss@husson.edu Why did you become a pharmacy professional?
More informationMAT in the Corrections Setting
MEDICATION ASSISTED TREATMENT AND CORRECTIONS Frank Filippelli, DO, PhD September 2017 MAT in the Corrections Setting Who Does This Affect? What is MAT and What is the Evidence of Efficacy? Emphasis on
More informationAddictions 101: Understanding, Recognizing, and Treating the Disease State!
Addictions 101: Understanding, Recognizing, and Treating the Disease State! www.overdosefreepa.org Criminal Justice Personnel Curricula Core Component 1 2014, Overdose Prevention Coalition! The OverdoseFreePA
More informationCombating Opioid-related Overdose
Combating Opioid-related Overdose Kelly Dunn, Ph.D. Assistant Professor Behavioral Pharmacology Research Unit Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine
More informationThe Role of Urgent Care in responding to the opioid Crisis
The Role of Urgent Care in responding to the opioid Crisis Robert S Crausman MD MMS Partner, Ocean State Urgent Care and Primary Care Centers Clinical Professor of Medicine, Brown Rob@OSUC.net Opioid Crisis
More informationOpioid Epidemic as it Relates to Counties
89 TH ANNUAL WEST TEXAS COUNTY JUDGES AND COMMISSIONERS ASSOCIATION CONFERENCE Wednesday, April 25, 2018 11:05 11:55 a.m. Opioid Epidemic as it Relates to Counties Ms. Jessica Cance Agency Analytics Unit
More informationUnderstanding the Opioid Crisis: What s at the Heart of the Matter?
National Center for Injury Prevention and Control Understanding the Opioid Crisis: What s at the Heart of the Matter? Sara Patterson Associate Director for Policy National Center for Injury Prevention
More informationTake Home Naloxone: Law Update and Considerations for Pharmacy Professionals
Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University
More informationPennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric
More informationAddressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationReducing opioid overdose mortality: role of communityadministered
Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)
More informationOpioid Use in Youth. Amy Yule M.D. March 2,
Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin
More informationNARCAN: THE HISTORY, APPLICATIONS AND FUTURE
NARCAN: THE HISTORY, APPLICATIONS AND FUTURE TABLE OF CONTENTS 3 Intro 4 What is Naloxone? 8 How Naloxone is Administered 12 Where to Find Narcan in California The United States accounts for about five
More informationOPIOIDS IN AMERICA. A complex crisis. A comprehensive response.
OPIOIDS IN AMERICA A complex crisis. A comprehensive response. There s only one way to successfully handle a situation this complex: with a coordinated response from every angle. Prescription opioids play
More informationTouchpoints Prior to Opioid Overdose Death
Touchpoints Prior to Opioid Overdose Death 7th Annual BU-CTSI Translational Science Symposium May 3, 2018 Marc Larochelle, MD, MPH Assistant Professor of Medicine Boston Medical Center and Boston University
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationBlue Cross of Idaho Addresses State s Opioid Issue
Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription
More informationMental Health and Behavioral Health
Mental Health and Behavioral Health mpfc (AC) Insula Thal DS GP VS VS VTA VTA Hippo OFC Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Advancing Addiction Science Behavioral
More informationSAMHSA/HHS: An Update on the Opioid Crisis
SAMHSA/HHS: An Update on the Opioid Crisis Elinore F. McCance-Katz, MD, PhD Assistant Secretary for Mental Health and Substance Use Substance Abuse and Mental Health Services Administration U.S. Department
More informationResearch Priorities of NIDA s Medications Development Program
Research Priorities of NIDA s Medications Development Program Iván D. Montoya, M.D., M.P.H. Deputy Director, Division of Therapeutics and Medical Consequences NIDA No Disclosures NIDA Medications Development
More informationMAT 101: TREATMENT OF OPIOID USE DISORDER
MAT 101: TREATMENT OF OPIOID USE DISORDER WITH SPECIAL EMPHASIS ON BUPRENORPHINE/NALOXONE ICADD May 22, 2018 Alicia Carrasco, MD Debby Woodall, LCSW, ACADC Magni Hamso, MD, MPH Terry Reilly Health Services
More informationPragmatic and Creative Responses to the Opioid Crisis in Connecticut
Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS
More informationAetna s Initiative on the Opioid Epidemic
Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationManagement of Opioid Use Disorder in Primary Care
1 Northwest ATTC presents Management of Opioid Use Disorder in Primary Care Joseph O. Merrill, MD, MPH University of Washington Associate Professor of Medicine 4/26/2018 Today s Presenter 2 Joseph Merrill,
More informationDivision of Mental Health and Addiction Services
Division of Mental Health and Addiction Services A DAM BUCON, LSW DMHAS Mission DMHAS, in partnership with consumers, family members, providers and other stakeholders, promotes wellness and recovery for
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More informationOpioid dependence and buprenorphine treatment
Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More informationOpioid Stewardship and Managing the Opioid Crisis: A Health-Care Perspective
Opioid Stewardship and Managing the Opioid Crisis: A Health-Care Perspective February 13, 2018 Frank Vocci, PhD New Therapies on the Horizon The planners, editors, faculty and reviewers of this activity
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationThe Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country
Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin
More informationPrescription Opioid Policies (22 March 2016)
Prescription Opioid Policies (22 March 2016) Prescription opioid misuse and abuse has become problematic in the United States and internationally in economically developed countries. Increased use of opioids
More informationThe Prescription Opioid and Heroin Crisis
The Prescription Opioid and Heroin Crisis Dr. Rachel L. Levine Acting Secretary of Health and Physician General Professor of Pediatrics and Psychiatry Penn State College of Medicine Overdose deaths from
More informationPrescribing Opioids in the Opioid Epidemic. Scott Woffinden, PA-C Jason Chapman, JD
Prescribing Opioids in the Opioid Epidemic Scott Woffinden, PA-C Jason Chapman, JD What's the Problem? http://www.zdoggmd.com/blank-script-taylor-swift-parody/ What's the Problem? CDC 115 Americans die
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationCoalition Strategies Across The Continuum of Care
Coalition Strategies Across The Continuum of Care Dorothy J. Chaney M.Ed. CADCA Consultant Building Safe, Healthy, and Drug Free Communities Overview and Objectives: By completing this training participants
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationThe Population is Abusing Drugs, but are Drugs Abusing Insurance?
Image licensed from Shutterstock The Population is Abusing Drugs, but are Drugs Abusing Insurance? 01/30/2018 Gina C. Guzman, MD, DBIM, FALU, FLMI, VP and Chief Medical Director Tim Morant, FSA, MAAA,
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationThe Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health
The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH Mississippi State Department of Health 1/12/2018 ACKNOWLEDGEMENTS DRUG ABUSE WORKING GROUP MISSISSIPPI STATE DEPARTMENT OF HEALTH Manuela Staneva,
More information